Full benefits develop over 2-3 cycles
Cagrilintide is a long-acting amylin analogue with dual amylin and calcitonin receptor activity, whereas semaglutide is a once-weekly GLP-1 receptor agonist with robust anti-hyperglycemic and appetite-suppressing effects
These effects depend on integrin alpha-1 and beta-1 pathway activation
They can have an opposite effect (most commonly) or parallel effect (note, this parallelism occurs with quite distinctive models, i.e., amphetamine-effect [70], miosis [91], atropine-mydriasis [91], huge magnesium over-dose [85], ischemic/reperfusion colitis [49], duodenal congestion lesions [251], cecum perforation [174])
Petrovic et al., 2006
[DOI] [PMC free article] [PubMed] [Google Scholar] 106.Mazzetti A.P., Fiorile M.C., Primavera A., Bello M.L